Cited by 128Diabetes Treatment and ManagementDiabetes Management and ResearchDiabetes Management and Education

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review

Open access

Andreozzi, F., Candido, R., Corrao, S., Fornengo, R., Giancaterini, A., Ponzani, P., Ponziani, M. C., Tuccinardi, F., Mannino, D.·2020·Diabetology & Metabolic Syndrome

DOI 10.1186/s13098-020-00559-7PMC PMC7301473

Open this paper in CoChat — free account Open PDF

Abstract

Diabetes mellitus is a chronic disease characterized by high social, economic and health burden, mostly due to the high incidence and morbidity of diabetes complications. Numerous studies have shown that optimizing metabolic control may reduce the risk of micro and macrovascular complications related to the disease, and the algorithms suggest that an appropriate and timely step of care intensification should be proposed after 3 months from the failure to achieve metabolic goals. Nonetheless, many population studies show that glycemic control in diabetic patients is often inadequate. The phenomenon of clinical inertia in diabetology, defined as the failure to start a therapy or its intensification/de-intensification when appropriate, has been studied for almost 20 years, and it is not limited to diabetes care, but also affects other specialties. In the present manuscript, we have documented the issue of inertia in its complexity, assessing its dimensions, its epidemiological weight, and its burden over the effectiveness of care. Our main goal is the identification of the causes of clinical inertia in diabetology, and the quantification of its social and health-related consequences through the adoption of appropriate indicators, in an effort to advance possible solutions and proposals to fight and possibly overcome clinical inertia, thus improving health outcomes and quality of care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/s13098-020-00559-7

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Untitled work
(2011) · Cited by 14,317
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Clinical Inertia
Phillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M., Gallina, D. L., Miller, C. D., Ziemer, D. C., & Barnes, C. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00012 · Cited by 1,370
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
Polonsky, W., & Henry, R. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s106821 · Cited by 784
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials
Zelniker, T. A., Wiviott, S. D., Raz, I., Im, K., Goodrich, E. L., Furtado, R. H. M., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038868 · Cited by 781
8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc18-s008 · Cited by 715
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes
Hayward, R. A., Reaven, P. D., Wiitala, W. L., Bahn, G. D., Reda, D. J., Ge, L., McCarren, M., Duckworth, W. C., & Emanuele, N. V. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414266 · Cited by 668
Insulin adherence behaviours and barriers in the multinational global attitudes of patients and physicians in insulin therapy study
Peyrot, M., Barnett, A. H., Meneghini, L. F., & Schumm‐Draeger, P. ‐. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03605.x · Cited by 655
Psychological Insulin Resistance in Patients With Type 2 Diabetes
Polonsky, W. H., Fisher, L., Guzman, S., Villa-Caballero, L., & Edelman, S. V. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2543 · Cited by 552
Potential overtreatment of diabetes mellitus in older adults with tight glycemic control
Lipska, K. J., Ross, J. S., Miao, Y., Shah, N. D., Lee, S. J., & Steinman, M. A. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.7345 · Cited by 408
Clinical Inertia in Response to Inadequate Glycemic Control
Shah, B. R., Hux, J. E., Laupacis, A., Zinman, B., & van Walraven, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.600 · Cited by 387
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review
Khunti, K., Gomes, M. B., Pocock, S., Shestakova, M. V., Pintat, S., Fenici, P., Hammar, N., & Medina, J. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13088 · Cited by 385
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
Perkovic, V., Heerspink, H. L., Chalmers, J., Woodward, M., Jun, M., Li, Q., MacMahon, S., Cooper, M. E., Hamet, P., Marre, M., et al. (2013) · Kidney International · doi:10.1038/ki.2012.401 · Cited by 316
Quality of Care of People With Type 2 Diabetes in Eight European Countries
Stone, M. A., Charpentier, G., Doggen, K., Kuß, O., Lindblad, U., Kellner, C., Nolan, J. J., Pazderska, A., Rutten, G. E. H. M., Trento, M., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1759 · Cited by 263
Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus
Reach, G., Pechtner, V., Gentilella, R., Corcos, A., & Ceriello, A. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.06.003 · Cited by 262
Identification of barriers to insulin therapy and approaches to overcoming them
Russell‐Jones, D., Pouwer, F., & Khunti, K. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13132 · Cited by 238
Fast and Slow
Ciardi, J. (1975) · Cited by 226
Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study
de Pablos‐Velasco, P., Parhofer, K. G., Bradley, C., Eschwège, E., Gönder-Frederick, L., Maheux, P., Wood, I., & Simon, D. (2014) · Clinical Endocrinology · doi:10.1111/cen.12119 · Cited by 218
Relationship Between Patient Medication Adherence and Subsequent Clinical Inertia in Type 2 Diabetes Glycemic Management
Grant, R. W., Adams, A. S., Trinacty, C. M., Zhang, F., KLEINMAN, K. P., Soumerai, S. B., Meigs, J. B., & Ross‐Degnan, D. (2007) · Diabetes Care · doi:10.2337/dc06-2170 · Cited by 218
Addressing Clinical Inertia in Type 2 Diabetes Mellitus: A Review
Okemah, J., Peng, J., & Quiñones, M. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0819-5 · Cited by 211
Competing Demands or Clinical Inertia: The Case of Elevated Glycosylated Hemoglobin
Parchman, M. L., Pugh, J. A., Romero, R. L., & Bowers, K. W. (2007) · The Annals of Family Medicine · doi:10.1370/afm.679 · Cited by 207
The Stepwise Approach to Diabetes Prevention: Results From the D-CLIP Randomized Controlled Trial
Weber, M. B., Ranjani, H., Staimez, L. R., Anjana, R. M., Ali, M. K., Narayan, K. M. V., & Mohan, V. (2016) · Diabetes Care · doi:10.2337/dc16-1241 · Cited by 192
Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia
Khunti, S., Khunti, K., & Seidu, S. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819844694 · Cited by 182
Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes
Greenfield, S., Billimek, J., Pellegrini, F., Franciosi, M., Berardis, G. D., Nicolucci, A., & Kaplan, S. H. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-12-200912150-00005 · Cited by 172
Breaking Down Patient and Physician Barriers to Optimize Glycemic Control in Type 2 Diabetes
Ross, S. A. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.06.012 · Cited by 162
Gaps and barriers in the control of blood glucose in people with type 2 diabetes
Blonde, L., Aschner, P. J., Bailey, C. J., Ji, L., Leiter, L. A., Matthaei, S., & Management, O. B. O. T. G. P. F. E. D. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116679775 · Cited by 160
Intensive treatment and severe hypoglycemia among adults with type 2 diabetes
McCoy, R. G., Lipska, K. J., Yao, X., Ross, J. S., Montori, V. M., & Shah, N. D. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2275 · Cited by 143
Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia
Thorpe, C. T., Gellad, W. F., Good, C. B., Zhang, S., Zhao, X., Mor, M., & Fine, M. J. (2015) · Diabetes Care · doi:10.2337/dc14-0599 · Cited by 140
Why system inertia makes health reform so difficult
Coiera, E. W. (2011) · BMJ · doi:10.1136/bmj.d3693 · Cited by 134
Reasons for not intensifying medications: differentiating “clinical inertia” from appropriate care
Safford, M. M., Shewchuk, R., Qu, H., Williams, J. H., Estrada, C. A., Ovalle, F., & Allison, J. J. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0433-8 · Cited by 132
Overcoming clinical inertia: a randomized clinical trial of a telehealth remote monitoring intervention using paired glucose testing in adults with type 2 diabetes
Greenwood, D. A., Blozis, S. A., Young, H. M., Nesbitt, T. S., & Quinn, C. C. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4112 · Cited by 128
Clinical inertia—time to reappraise the terminology?
Khunti, K., & Davies, M. J. (2017) · Primary Care Diabetes · doi:10.1016/j.pcd.2017.01.007 · Cited by 121
Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus
Strain, W. D., Cos, X., Hirst, M., Vencio, S. A. C., Mohan, V., Vokó, Z., Yabe, D., Blüher, M., & Paldánius, P. M. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.05.005 · Cited by 116
Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice
Khunti, K., Damcı, T., Meneghini, L., Pan, C., Yale, J., & on behalf of the SOLVE Study Group (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01602.x · Cited by 114
Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: the DA Qing IGT and Diabetes Study
Li, G., Hu, Y., Yang, W., Yayun, J., Wang, J., Xiao, J., Hu, Z., Pan, X.-R., Howard, B. V., & Bennett, P. H. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00175-4 · Cited by 109
Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care: a qualitative study
Zafar, A., Stone, M. A., Davies, M. J., & Khunti, K. (2015) · Diabetic Medicine · doi:10.1111/dme.12592 · Cited by 103
Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System
Pantalone, K. M., Wells, B. J., Chagin, K. M., Ejzykowicz, F., Yu, C., Milinovich, A., Bauman, J. M., Kattan, M. W., Rajpathak, S. N., & Zimmerman, R. S. (2016) · Diabetes Care · doi:10.2337/dc16-0227 · Cited by 97
Clinical inertia in management of T2DM
Zafar, A., Davies, M. J., Azhar, A., & Khunti, K. K. (2010) · Primary care diabetes · doi:10.1016/j.pcd.2010.07.003 · Cited by 91
Clinical Inertia as a Clinical Safeguard
Giugliano, D. (2011) · JAMA · doi:10.1001/jama.2011.490 · Cited by 91
Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study
Oellgaard, J., Gæde, P., Rossing, P., Rørth, R., Køber, L., Parving, H.-H., & Pedersen, O. (2018) · Diabetologia · doi:10.1007/s00125-018-4642-y · Cited by 86
Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy
Fu, A. Z., Qiu, Y., Davies, M. J., Radican, L., & Engel, S. S. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01405.x · Cited by 78
Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment
Mata‐Cases, M., Franch‐Nadal, J., Real, J., Gratacòs, M., López‐Simarro, F., Khunti, K., & Mauricio, D. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13045 · Cited by 72
Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care
Mata-Cases, M., Benito-Badorrey, B., Roura-Olmeda, P., Franch-Nadal, J., Pepió-Vilaubí, J. M., Saez, M., Coll-de-Tuero, G., & on behalf of the GEDAPS (Primary Care Group for the study of Diabetes) of the Catalonian Society of Family and Community Medicine (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.833089 · Cited by 70
Frequency of inappropriate medical exceptions to quality measures
Persell, S. D., Dolan, N. C., Friesema, E. M., Thompson, J. A., Kaiser, D., & Baker, D. W. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-4-201002160-00007 · Cited by 66
Nonadherence, Clinical Inertia, or Therapeutic Inertia?
Allen, J. D., Curtiss, F. R., & Fairman, K. A. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.8.690 · Cited by 66
Decision making under uncertainty, therapeutic inertia, and physicians’ risk preferences in the management of multiple sclerosis (DIScUTIR MS)
Saposnik, G., Sempere, Á. P., Raptis, R., Prefasi, D., Selchen, D. H., & Mauriño, J. (2016) · BMC Neurology · doi:10.1186/s12883-016-0577-4 · Cited by 53
Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK
Bain, S. C., Bekker Hansen, B., Hunt, B., Chubb, B., & Valentine, W. J. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2019.1645018 · Cited by 53
An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment
Makam, A. N., & Nguyen, O. K. (2017) · Circulation · doi:10.1161/circulationaha.116.022622 · Cited by 52
Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A retrospective cohort study: 临床惰性可导致2型糖尿病患者新发视网膜病变或视网膜病变进展:一项回顾性队列研究
Osataphan, S., Chalermchai, T., & Ngaosuwan, K. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12410 · Cited by 49
Treatment Intensification in a Hypertension Telemanagement Trial
Crowley, M. J., Smith, V. A., Olsen, M. K., Danus, S. M., Oddone, E. Ž., Bosworth, H. B., & Powers, B. J. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.174367 · Cited by 47
Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE study
Muller, N., Khunti, K. K., Kuß, O., Lindblad, U., Nolan, J. J., Rutten, G. E. H. M., Trento, M., Porta, M., Roth, J., Charpentier, G., et al. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0939-9 · Cited by 44
Clinical inertia, uncertainty and individualized guidelines
Reach, G. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.12.009 · Cited by 40
Family Physician Clinical Inertia in Glycemic Control among Patients with Type 2 Diabetes
Kranjčević, K. (2015) · Medical Science Monitor · doi:10.12659/msm.892248 · Cited by 39
Assessment of short and long-term outcomes of diabetes patient education using the health education impact questionnaire (HeiQ)
Laursen, D. H., Christensen, K. B., Christensen, U., & Frølich, A. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2536-6 · Cited by 37
Inercia clínica en pacientes con diabetes mellitus tipo 2 no insulinizados en tratamiento con hipoglucemiantes orales. Estudio INERCIA
González-Clemente, J. M., Font, B., Lahoz, R., Llauradó, G., & Gambús, G. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2013.02.032 · Cited by 28
Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis
Ruiz‐Negrón, N., Wander, C., McAdam‐Marx, C., Pesa, J. A., Bailey, R. A., & Bellows, B. K. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.25.3.304 · Cited by 27
Clinical inertia in type 2 diabetes: a retrospective analysis of pharmacist-managed diabetes care vs. usual medical care
Yam, F. K., Adams, A. G., Divine, H. S., Steinke, D. T., & Jones, M. D. (2013) · Pharmacy Practice · doi:10.4321/s1886-36552013000400005 · Cited by 26
Improving treatment success rates for type 2 diabetes: recommendations for a changing environment.
Triplitt, C. L. (2010) · PubMed · Cited by 25
Therapeutic inertia in type 2 diabetes: Insights from the PANORAMA study in France
Simon, D. (2012) · Diabetes & Metabolism · doi:10.1016/s1262-3636(12)71534-3 · Cited by 23
High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study
Campbell, M. D., Babić, D., Bolcina, U., Duvnjak, L. S., Tankova, T. I., Mitrakou, A., Kempler, P., & Janež, A. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01346-1 · Cited by 21
Identificación de los factores que influyen en el retraso intrahospitalario del inicio de trombólisis intravenosa en el ictus agudo en un hospital terciario
Mohedano, A. M. I., Pastor, Á. G., Arratibel, A. G., García, P. S., Otero, F. D., Delgado, F. R., Rubio, R. D., González, A. M., Alén, P. V., Bullido, Y. F., et al. (2015) · Neurología · doi:10.1016/j.nrl.2014.12.004 · Cited by 21
Insights Into the Current Management of Older Adults With Type 2 Diabetes in the Ontario Primary Care Setting
Meneilly, G. S., Berard, L., CHENG, A. Y. Y., Lin, P., MacCallum, L., Tsuyuki, R. T., Yale, J., Nasseri, N., Richard, J.-F., Goldin, L., et al. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.03.003 · Cited by 20
Patient and Provider Factors Affecting Clinical Inertia in Patients With Type 2 Diabetes on Metformin Monotherapy
Mahabaleshwarkar, R., Gohs, F. X., Mulder, H., Wilkins, N., DeSantis, A., Anderson, W. E., Ejzykowicz, F., Rajpathak, S. N., & Norton, H. J. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.06.011 · Cited by 19
Clinical inertia in basal insulin-treated patients with type 2 diabetes – Results from a retrospective database study in Japan (JDDM 43)
Satoh, J., Andersen, M., Hansen, B. B., Thorsted, B. L., Tutkunkardas, D., Zacho, M., & Maegawa, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198160 · Cited by 19
Clinical inertia: viewpoints of general practitioners and diabetologists
Avignon, A., Attali, C., Sultan, A., Ferrat, É., & Breton, J. L. (2012) · Diabetes & Metabolism · doi:10.1016/s1262-3636(12)71535-5 · Cited by 17
The B-SMART Appropriate Medication-Use Process: A Guide for Clinicians to Help Patients— Part 1: Barriers, Solutions, and Motivation
Oyekan, E., Nimalasuriya, A., Martin, J., Scott, R., Dudl, R. J., & Green, K. (2009) · The Permanente Journal · doi:10.7812/tpp/07-057 · Cited by 17
Results from the UK cohort of SOLVE: Providing insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice
Khunti, K. K., Vora, J. P., & Davies, M. J. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2013.11.010 · Cited by 14
Clinical inertia on insulin treatment intensification in type 2 diabetes mellitus patients of a tertiary public diabetes center with limited pharmacologic armamentarium from an upper-middle income country
Alvarenga, M. A., Komatsu, W. R., de Sá, J. R., Chacra, A. R., & Dib, S. A. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0382-x · Cited by 14
Factors associated with in-hospital delays in treating acute stroke with intravenous thrombolysis in a tertiary centre
Mohedano, A. M. I., Pastor, Á. G., Arratibel, A. G., García, P. S., Otero, F. D., Delgado, F. R., Rubio, R. D., González, A. M., Alén, P. V., Bullido, Y. F., et al. (2016) · Neurología (English Edition) · doi:10.1016/j.nrleng.2014.12.012 · Cited by 13
Telehealth-Assisted Care Coordination of Older Veterans with Type 2 Diabetes Lowers Coronary Heart Disease Risk Despite Clinical Inertia
Dang, S., Sanchez, A., Oropesa, L., Roos, B. A., & Florez, H. J. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0066 · Cited by 11
Hypertension Treatment in Patients with Metabolic Syndrome and/or Type 2 Diabetes Mellitus: Analysis of the Therapy Effectivity and the Therapeutic Inertia in Outpatient Study
Farsky, S., Strišková, A., & Borčin, M. (2018) · Cardiology Research and Practice · doi:10.1155/2018/8387613 · Cited by 11
High Quality of Diabetes Care Based Upon Individualised Treatment Goals – A Cross Sectional Study in 4784 Patients in Germany
Kloos, C., Muller, N., Hartmann, P., Lehmann, T., Sämann, A., Roth, J., Wolf, G., & Müller, U. (2016) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0035-1569380 · Cited by 11
Physician Reasons for Nonpharmacologic Treatment of Hyperglycemia in Older Patients Newly Diagnosed with Type 2 Diabetes Mellitus
Marrett, E., Zhang, Q., Kanitscheider, C., Davies, M. J., Radican, L., & Feinglos, M. N. (2012) · Diabetes Therapy · doi:10.1007/s13300-012-0005-8 · Cited by 11
Expanding the concept of ‘Clinical Inertia’ in diabetes
Mohan, V. (2018) · Journal of Diabetology · doi:10.4103/jod.jod_44_18 · Cited by 8
Dyslipidemia: The untreated metabolic dysfunction in people with type 2 diabetes in Latin America. ARETAEUS study outcomes
Gagliardino, J. J., Arechavaleta, R., Eliaschewitz, F. G., Iglay, K., Brodovicz, K. G., González, C. D., Yu, S., Shankar, R. R., Heisel, O., Keown, P. A., et al. (2019) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2019.01.002 · Cited by 7
A Multicenter Italian Survey on Diabetes Care Units Reveals a Somewhat Slow Attitude in Treatment Guideline Implementation: Are We Dealing With Therapeutic Inertia?
Gentile, S., Ceriello, A., IRCCS MultiMedica, M., Strollo, F., & START DIAB Study Group Members (2016) · Diabetes Research - Open Journal · doi:10.17140/droj-2-127 · Cited by 6
Continuing Educational Inertia?
Peters, K. R. (2014) · Clinical Diabetes · doi:10.2337/diaclin.32.3.97 · Cited by 4
Clinical inertia among patients with type 2 diabetes mellitus treated with DPP-4i and/or SGLT-2i
Lanzinger, S., Schmid, S. M., Welp, R., Zimmermann, A., Fasching, P., Wagner, S., & Holl, R. W. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.011 · Cited by 4
Diabetologist's core competence curriculum: A position statement of the amd (Italian association of medical diabetologists)
Musacchio, N., idom, Cimino, A., Micheli, A., Giancaterini, A., Monge, L., Ozzello, A., Pellegrini, M. A., Ponziani, M. C., Ragonese, M., et al. (2019) · Diabetes Management · doi:10.37532/1758-1907.2019.9(4).87-95 · Cited by 4
Self-citation
More and more elderly diabetics: toward evidence-based deprescribing?
Micheli, A. D. (2018) · The Journal of AMD · doi:10.36171/jamd18.21.1.02 · Cited by 1

Research works printed but not linked: 3

Annals of AMD 2018. Assessment of AMD diabetes quality assistence indicators in Italy; 2018. https://aemmedi.it/wp-content/uploads/2019/05/AMD-Monografia-SGLT-2i-web-protetto.pdf. Accessed 27 Sept 2019.
Monographs of the Annals of AMD 2012. Focus on changes to treatment in type 2 diabetes. 2012. http://www.infodiabetes.it/files/ANNALI-AMD/2013/Annali%202013%20Terapie%20per%20web.pdf. Accessed 5 Nov 2019.
Pellegrini MA, Ercoli A, Musacchio N, Zilich R, Mannino D. Inerzia terapeutica del Diabetologo: dall’algoritmo clinico all’algoritmo mentale. Progetto DIADEMA-AMD. J AMD. 2019;22:9.

Sorted by citations

Artificial intelligence for diabetes care: current and future prospects
Sheng, B., Pushpanathan, K., Guan, Z., Lim, Q. H., Lim, Z. W., Yew, S. M. E., Goh, J. H. L., Bee, Y. M., Sabanayagam, C., Sevdalis, N., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00154-2 · Cited by 106
Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease
Nee, R., Yuan, C. M., Narva, A. S., Yan, G., & Norris, K. C. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac283 · Cited by 83
Algae-Derived Natural Products in Diabetes and Its Complications—Current Advances and Future Prospects
Pereira, L., & Valado, A. (2023) · Life · doi:10.3390/life13091831 · Cited by 59
Clinical Inertia in the Management of Type 2 Diabetes Mellitus: A Systematic Review
Almigbal, T. H., Alzarah, S. A., Aljanoubi, F. A., Alhafez, N. A., Aldawsari, M. R., Alghadeer, Z. Y., & Alrasheed, A. A. (2023) · Medicina · doi:10.3390/medicina59010182 · Cited by 58
“In terms of optimal management of diabetes, clinical inertia is a remarkable barrier to therapeutic success, because it delays the intensification of treatment [10].”
BackgroundInfluential
Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK
Bain, S. C., Bekker Hansen, B., Hunt, B., Chubb, B., & Valentine, W. J. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2019.1645018 · Cited by 53

See all 128

Authors: Andreozzi, F., Candido, R., Corrao, S., Fornengo, R., Giancaterini, A., Ponzani, P., Ponziani, M. C., Tuccinardi, F., & Mannino, D.
Affiliations: Magna Graecia University (IT)
Azienda Sanitaria Universitaria Integrata di Trieste (IT)
University of Palermo (IT)
Azienda ospedaliera "Bianchi-Melacrino-Morelli" (IT)
Corresponding author: Andreozzi, F.
ORCID: Andreozzi, F.
Candido, R.
Corrao, S.
Giancaterini, A.
Ponzani, P.
Venue: Diabetology & Metabolic Syndrome
Publisher: Springer Science and Business Media LLC
Published: 2020-06-17
Volume: 12
Issue: 1
Pages: 52-52
ISSN: 1758-5996 (ISSN-L)
DOI: 10.1186/s13098-020-00559-7
PMC: PMC7301473
OpenAlex: W3036158386
Cited by: 128
References: 89
Citations by year: 2026: 12 · 2025: 16 · 2024: 27 · 2023: 25 · 2022: 22 · 2021: 23 · 2020: 2
FWCI: 2.76
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Diabetology & Metabolic Syndrome (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
Funders: MSD Italia
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords: clinical inertia, diabetes mellitus, glycemic control, diabetes complications, microvascular complications, macrovascular complications, treatment intensification, quality of care, health outcomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks